» Authors » Gordon Robertson

Gordon Robertson

Explore the profile of Gordon Robertson including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 39
Citations 4774
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Wang P, Robertson G, Gibson B, Fancher C, Reynolds J, Borish M, et al.
3D Print Addit Manuf . 2024 Feb; 11(1):231-241. PMID: 38389668
Laser powder bed fusion (LPBF) enables the fabrication of intricate, geometrically complex structures with a sufficiently fine surface finish for many engineering applications with a diversity of available feedstock metals....
2.
Robertson G, McCulloch M, Wearne N, Jones E, Barday Z, Blumenthal A, et al.
Kidney Int Rep . 2022 Jul; 7(7):1711-1715. PMID: 35812276
No abstract available.
3.
Robertson G, Ellis S, Yu Q, Bland-Hawthorn J, Betters C, Roth M, et al.
Appl Opt . 2021 Jul; 60(19):D122-D128. PMID: 34263851
Celestially, positronium (Ps) has been observed only through gamma-ray emission produced by its annihilation. However, in its triplet state, a Ps atom has a mean lifetime long enough for electronic...
4.
Korkut A, Zaidi S, Kanchi R, Rao S, Gough N, Schultz A, et al.
Cell Syst . 2018 Oct; 7(4):422-437.e7. PMID: 30268436
We present an integromic analysis of gene alterations that modulate transforming growth factor β (TGF-β)-Smad-mediated signaling in 9,125 tumor samples across 33 cancer types in The Cancer Genome Atlas (TCGA)....
5.
Radovich M, Pickering C, Felau I, Ha G, Zhang H, Jo H, et al.
Cancer Cell . 2018 Feb; 33(2):244-258.e10. PMID: 29438696
Thymic epithelial tumors (TETs) are one of the rarest adult malignancies. Among TETs, thymoma is the most predominant, characterized by a unique association with autoimmune diseases, followed by thymic carcinoma,...
6.
Lerner S, Weinstein J, Kwiatkowski D, Kim J, Robertson G, Hoadley K, et al.
Eur Urol Focus . 2017 Jul; 1(1):94-95. PMID: 28723366
The Cancer Genome Atlas project in bladder cancer reported the integrated genomic analysis of the first 131 patients in 2014. This muscle-invasive cohort was found to have one of the...
7.
Pan Y, Robertson G, Pedersen L, Lim E, Hernandez-Herrera A, Rowat A, et al.
Oncotarget . 2017 Apr; 8(10):17406. PMID: 28403581
No abstract available.
8.
Cherniack A, Shen H, Walter V, Stewart C, Murray B, Bowlby R, et al.
Cancer Cell . 2017 Mar; 31(3):411-423. PMID: 28292439
We performed genomic, epigenomic, transcriptomic, and proteomic characterizations of uterine carcinosarcomas (UCSs). Cohort samples had extensive copy-number alterations and highly recurrent somatic mutations. Frequent mutations were found in TP53, PTEN,...
9.
Pan Y, Robertson G, Pedersen L, Lim E, Hernandez-Herrera A, Rowat A, et al.
Oncotarget . 2016 Apr; 7(18):25930-48. PMID: 27036018
Ovarian cancer presents as an aggressive, advanced stage cancer with widespread metastases that depend primarily on multicellular spheroids in the peritoneal fluid. To identify new druggable pathways related to metastatic...
10.
Ciriello G, Gatza M, Beck A, Wilkerson M, Rhie S, Pastore A, et al.
Cell . 2015 Oct; 163(2):506-19. PMID: 26451490
Invasive lobular carcinoma (ILC) is the second most prevalent histologic subtype of invasive breast cancer. Here, we comprehensively profiled 817 breast tumors, including 127 ILC, 490 ductal (IDC), and 88...